59101-27-8

Basic information

• Product Name: 15-BROMO-1-PENTADECANOL
• Synonyms: 15-BROMO-1-PENTADECANOL;15-BROMO-PENTADECAN-1-OL;VITAS-BB TBB000205;1-Pentadecanol, 15-broMo-
• CAS NO: 59101-27-8
• Molecular Formula: C₁₅H₃₁BrO
• Molecular Weight: 307.31
• Product Categories: CMLLYL
• Mol File: 59101-27-8.mol

Chemical Properties

• Melting Point: 63.6-64.1 °C
• Boiling Point: 368.9 °C at 760 mmHg
• Flash Point: 133 °C
• Appearance: /
• Density: 1.071 g/cm³
• Vapor Pressure: 6.09E-07mmHg at 25°C
• Refractive Index: 1.475
• Storage Temp.: 2-8°C
• PKA: 15.20±0.10(Predicted)
• CAS DataBase Reference: 15-BROMO-1-PENTADECANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 15-BROMO-1-PENTADECANOL(59101-27-8)
• EPA Substance Registry System: 15-BROMO-1-PENTADECANOL(59101-27-8)

Safety Data

• Hazardous Substances Data: 59101-27-8(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
15-BROMO-1-PENTADECANOL is used as a precursor in organic synthesis for the production of a variety of other organic compounds. Its unique structure allows for the creation of diverse chemical entities, making it a valuable component in the synthesis process.
Used in Cosmetic and Personal Care Products:
In the cosmetic and personal care industry, 15-BROMO-1-PENTADECANOL is used as a potential surfactant or emulsifier due to its long carbon chain. This application helps in stabilizing formulations and improving the texture and performance of products.
Used in Pharmaceutical Industry:
15-BROMO-1-PENTADECANOL may have applications in the pharmaceutical field, potentially serving as an intermediate in the synthesis of pharmaceutical agents or contributing to the development of new drug compounds.
Used in Agrochemicals:
Similarly, in the agrochemical sector, 15-BROMO-1-PENTADECANOL could be utilized in the synthesis of various agrochemical products, playing a role in the development of pesticides, herbicides, or other agricultural chemicals.
It is important to consider the health and environmental hazards associated with 15-BROMO-1-PENTADECANOL, ensuring that appropriate safety measures are implemented during its handling and use across different industries.

InChI:InChI=1/C15H31BrO/c16-14-12-10-8-6-4-2-1-3-5-7-9-11-13-15-17/h17H,1-15H2

Upstream product

• 869734-95-2 methyl 15-((methylsulfonyl)oxy)pentadecanoate 
• 106-02-5 pentadecanolide 
• 14722-40-8 1,15-pentadecanediol 
• 10035-10-6 hydrogen bromide 
• 1460-18-0 pentadecanedioic acid 
• 76529-42-5 methyl 15-hydroxypentadecanoate 
• 41240-56-6 15-bromopentadecanoic acid methyl ester 
• 101592-34-1 15-bromo-ethyl-pentadecanoate 
• 56523-59-2 15-bromo-pentadecanoic acid 
• 16346-16-0 pentadec-14-en-1-ol 
• 871888-39-0 1,15-dimethoxy-pentadecane 

Downstream Products

• 59100-02-6 4-(15-Hydroxy-pentadecyloxy)-benzoic acid methyl ester 
• 132910-90-8 (15-bromopentadecyloxy)(tert-butyl)diphenylsilane 
• 1391985-80-0 17-(tert-butyldiphenylsilyloxy)-N-methoxy-N-methyl-2-(prop-1-en-2-yl)heptadecanamide 
• 1391985-72-0 tert-butyl(15-iodopentadecyloxy)diphenylsilane 

Relevant articles and documents

A simple technique to grow polymer brushes using in situ surface ligation of an organometallic initiator

A simple approach is described here for the in-place synthesis of polymer brushes by surface-initiated polymerization. A cyano-terminated self-assembled monolayer on a gold surface was used to anchor a highly active cationic Pd organometallic initiator by ligand exchange. We grew ultrasmooth patterned poly(4-methoxystyrene) brushes with excellent thickness control at room temperature. Copyright

DIENE GEMINI POLYMERIZABLE SURFACTANTS WITH MIXED CIS AND TRANS ISOMERS THAT FORM BICONTINUOUS CUBIC PHASES

A polymerizable Gemini surfactant based on tail groups with mixed isomer dienes. The Gemini surfactants may be produced having imidazolium head groups and diene tail groups with a near-equal abundance of the ?" and "Z" isomers. These compounds are lyotropic liquid crystals that can form bicontinuous cubic phases by self-assembly.

Synthesis of [3]rotaxanes that utilize the catalytic activity of a macrocyclic phenanthroline-Cu complex: Remarkable effect of the length of the axle precursor

[3]Rotaxanes, which consist of one macrocyclic phenanthroline compound and two axle components, were prepared by the oxidative dimerization of an alkyne compound with bulky tris[4'-cyclohexyl-(1,1'-biphenyl)-4-yl]methyl blocking group. The catalytic activ

Synthesis of new ligands for targeting the S1P1 receptor

Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P1-5). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P1 receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [18F]-labelling. The radioligands shall enable the imaging of S1P1 receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases.

New fluorinated agonists for targeting the sphingosin-1-phosphate receptor 1 (S1P1)

The sphingosine-1-phosphate receptor type 1 (S1P1) is involved in fundamental biological processes such as regulation of immune cell trafficking, vascular barrier function and angiogenesis. This Letter presents multistep syntheses of various fluorine substituted 12-aryl analogues of the drug fingolimod (FTY720) and a seven-steps route to 2-amino-17,17-difluoro-2-(hydroxymethyl)heptadecan-1-ol. In vitro and in vivo tests proved all these compounds as potent S1P1 receptor agonists.

NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES

The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogues, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.

NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES

The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogues, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.

General synthesis and aggregation behaviour of a series of single-chain 1,ω-Bis(phosphocholines)

The synthesis and physicochemical characterisation of a series of polymethylene-1,ω-bis(phosphocholines) with even-numbered chain lengths between 22 and 32 carbon atoms is described. Two new synthetic strategies for the preparation of long-chain 1,ω-diols as hydrocarbon building blocks are presented. The temperature-dependent self-assembly of the single-chain bolaamphiphiles was investigated by cryo transmission electron microscopy (cryo-TEM), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR).

The introduction of π-π stacking moieties for fabricating stable micellar structure: Formation and dynamics of disklike micelles

(Figure Presented) Enhancing the intermolecular interactions between micelles by introducing a strong π-π stacking moiety and flexible spacers of appropriate length results in the formation of disklike micelles that can maintain their monomolecule-layered

PROCESS FOR PRODUCING CYCLOHEXENONE LONG-CHAIN ALCOHOLS

A process for producing cyclohexenone long-chain alcohol represented by the following formula (1): (wherein A represents a C10-C18 alkylene or alkenylene group, and each of R1, R2, and R3 individually represents hydrogen o